The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.Investors Business Daily • 05/20/25
Moderna: After A Crash From $500 To $25, I'm Buying This "Call Option" On Pandemics And CancerSeeking Alpha • 05/20/25
S&P500 and Nasdaq Index: Consumer Data Sinks Sentiment, Super Micro, Moderna RallyFXEmpire • 05/16/25
Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025Accesswire • 05/08/25
Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1Zacks Investment Research • 05/06/25
Moderna faces long-term threat from NIH's universal vaccine initiative, Jefferies saysProactive Investors • 05/02/25
Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026Benzinga • 05/01/25
Moderna Beats on Q1 Earnings, Lags on Revenues, Focuses on Cost CutsZacks Investment Research • 05/01/25
Moderna Reports First Quarter 2025 Financial Results and Provides Business UpdatesAccesswire • 05/01/25
Countdown to Moderna (MRNA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 04/28/25